Qyuns Therapeutics Co., Ltd. (HKG: 2509)
Hong Kong
· Delayed Price · Currency is HKD
12.00
-1.00 (-7.69%)
Nov 15, 2024, 10:33 AM HKT
Qyuns Therapeutics Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Other Revenue | 14.75 | 14.75 | 9.66 | 21.35 |
| Revenue | 59.67 | 14.75 | 9.66 | 21.35 |
| Revenue Growth (YoY) | 517.57% | 52.67% | -54.74% | - |
| Gross Profit | 52.51 | 14.75 | 9.66 | 21.35 |
| Selling, General & Admin | 136.16 | 164.59 | 76.6 | 48.8 |
| Research & Development | 340.79 | 364.4 | 257.21 | 151.89 |
| Operating Expenses | 478.9 | 529 | 333.82 | 200.69 |
| Operating Income | -426.39 | -514.25 | -324.16 | -179.34 |
| Interest Expense | -22.87 | -16.82 | -18.69 | -17.84 |
| Interest & Investment Income | 5.16 | 4.47 | 4.17 | 7.06 |
| Currency Exchange Gain (Loss) | 0.77 | -0.43 | 14.46 | -2.72 |
| Other Non Operating Income (Expenses) | -0.01 | -0.01 | -0.06 | -240.18 |
| EBT Excluding Unusual Items | -443.33 | -527.04 | -324.28 | -433.02 |
| Gain (Loss) on Sale of Investments | 4.5 | 5.7 | 11.9 | 6.48 |
| Pretax Income | -438.83 | -521.33 | -312.38 | -426.54 |
| Income Tax Expense | -0.07 | -0.07 | -0.07 | -0.07 |
| Earnings From Continuing Operations | -438.76 | -521.26 | -312.31 | -426.47 |
| Minority Interest in Earnings | 16.96 | 13.51 | 14.12 | 15.43 |
| Net Income | -421.8 | -507.75 | -298.19 | -411.04 |
| Preferred Dividends & Other Adjustments | - | - | - | -112.77 |
| Net Income to Common | -421.8 | -507.75 | -298.19 | -298.27 |
| Shares Outstanding (Basic) | 213 | 206 | 178 | 116 |
| Shares Outstanding (Diluted) | 213 | 206 | 178 | 116 |
| Shares Change (YoY) | 20.04% | 15.67% | 52.95% | - |
| EPS (Basic) | -1.98 | -2.47 | -1.68 | -2.57 |
| EPS (Diluted) | -1.98 | -2.47 | -1.68 | -2.57 |
| Free Cash Flow | -202.99 | -308.56 | -245.33 | -180.55 |
| Free Cash Flow Per Share | -0.95 | -1.50 | -1.38 | -1.55 |
| Gross Margin | 88.00% | 100.00% | 100.00% | 100.00% |
| Operating Margin | -714.58% | -3486.18% | -3354.95% | -840.05% |
| Profit Margin | -706.89% | -3442.13% | -3086.22% | -1397.13% |
| Free Cash Flow Margin | -340.19% | -2091.76% | -2539.08% | -845.71% |
| EBITDA | -395.92 | -484.12 | -295.51 | -155.65 |
| D&A For EBITDA | 30.47 | 30.13 | 28.65 | 23.7 |
| EBIT | -426.39 | -514.25 | -324.16 | -179.34 |
Source: S&P Capital IQ. Standard template.
Financial Sources.